These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3149342)

  • 21. [Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1994 Jul; 52(7):1823-7. PubMed ID: 8078202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy.
    Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.
    Alberti A
    J Hepatol; 2005 Feb; 42(2):266-74. PubMed ID: 15664254
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis.
    Miyake K; Tango T; Ota Y; Mitamura K; Yoshiba M; Kako M; Hayashi S; Ikeda Y; Hayashida N; Iwabuchi S; Sato Y; Tomi T; Funaki N; Hashimoto N; Umeda T; Miyazaki J; Tanaka K; Endo Y; Suzuki H
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1198-204. PubMed ID: 12453280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI
    Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
    Orlent H; Hansen BE; Willems M; Brouwer JT; Huber R; Kullak-Ublick GA; Gerken G; Zeuzem S; Nevens F; Tielemans WC; Zondervan PE; Lagging M; Westin J; Schalm SW
    J Hepatol; 2006 Oct; 45(4):539-46. PubMed ID: 16905220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic non-A, non-B hepatitis.
    Hoofnagle JH; Alter HJ
    Prog Clin Biol Res; 1985; 182():63-9. PubMed ID: 3929263
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiviral agents in the treatment of chronic viral hepatitis.
    Perrillo RP
    Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
    [No Abstract]   [Full Text] [Related]  

  • 30. Personalized therapy in chronic viral hepatitis.
    Brunetto MR; Colombatto P; Bonino F
    Mol Aspects Med; 2008; 29(1-2):103-11. PubMed ID: 18068759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term analysis of non-A, non-B hepatitis--clinical, histologic and immunologic findings].
    Wiese M; Haupt R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):103-12. PubMed ID: 2424712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New antiviral agents in chronic viral hepatitis].
    Gómez Cedenilla A; Zapater Hernández P; García Buey L; Abad Santos F; García Monzón C; González Mateos F; Moreno Otero R
    Rev Clin Esp; 1998 Feb; 198(2):104-13. PubMed ID: 9558926
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physical endurance of patients with chronic hepatitis. The standardized treadmill test of 95 patients with liver biopsy verified disease].
    Müting D; Kalk JF; Bretscher C; Wuzel H
    Med Klin (Munich); 1987 Jun; 82(14):467-71, 508. PubMed ID: 3112534
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preventive and therapeutic actions of glycyrrhizin, glycyrrhetic acid and crude saikosides on experimental liver cirrhosis in rats].
    Zhao MQ; Han DW; Ma XH; Zhao YC; Yin L; Li CM
    Yao Xue Xue Bao; 1983 May; 18(5):325-31. PubMed ID: 6637483
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection.
    Da Nagao Y; Sata M; Suzuki H; Tanikawa K; Itoh K; Kameyama T
    J Gastroenterol; 1996 Oct; 31(5):691-5. PubMed ID: 8887036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone.
    Scotto G; Fazio V; Tantimonaco G
    Ital J Gastroenterol; 1996 Dec; 28(9):505-11. PubMed ID: 9131395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.